These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10371421)
41. In vivo application of non-viral vectors to the liver. Richardso P; Kren BT; Steer CJ J Drug Target; 2002 Mar; 10(2):123-31. PubMed ID: 12074539 [TBL] [Abstract][Full Text] [Related]
42. [Lipids in drugs]. Shvets VI; Krasnopol'skiĭ IuM Vestn Akad Med Nauk SSSR; 1990; (6):19-28. PubMed ID: 2120858 [TBL] [Abstract][Full Text] [Related]
43. Recent advances in gene therapy of GI and liver diseases. Wu GY Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(5):297-300. PubMed ID: 9823673 [TBL] [Abstract][Full Text] [Related]
44. Synthesis of cholesterol-based neoglycoconjugates and their use in the preparation of liposomes for active liver targeting. E Silva ATM; Maia ALC; de Oliveira Silva J; de Barros ALB; Soares DCF; de Magalhães MTQ; José Alves R; Ramaldes GA Carbohydr Res; 2018 Jul; 465():52-57. PubMed ID: 29944996 [TBL] [Abstract][Full Text] [Related]
45. Gene therapy: The state of the art and future directions. Giordano C; Causa F; Candiani G J Appl Biomater Biomech; 2006; 4(2):73-9. PubMed ID: 20799205 [TBL] [Abstract][Full Text] [Related]
46. Targeted vectors for gene therapy. Miller N; Vile R FASEB J; 1995 Feb; 9(2):190-9. PubMed ID: 7781922 [TBL] [Abstract][Full Text] [Related]
47. Nano-vectors for efficient liver specific gene transfer. Pathak A; Vyas SP; Gupta KC Int J Nanomedicine; 2008; 3(1):31-49. PubMed ID: 18488414 [TBL] [Abstract][Full Text] [Related]
48. [Progresses on active targeting liposome drug delivery systems for tumor therapy]. Zhang M; Lou C; Cao A Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2022 Jun; 39(3):633-638. PubMed ID: 35788534 [TBL] [Abstract][Full Text] [Related]
49. Progress toward a synthetic virus : a multicomponent system for liver-directed DNA delivery. Zhong BH; Wu GY; Wu CH Methods Mol Med; 2001; 65():111-21. PubMed ID: 21318749 [TBL] [Abstract][Full Text] [Related]
50. Nanoencapsulated and microencapsulated enzymes in drug antidotal therapy. Szilasi M; Budai M; Budai L; Petrikovics I Toxicol Ind Health; 2012 Jul; 28(6):522-31. PubMed ID: 21986886 [TBL] [Abstract][Full Text] [Related]
51. Liposome technology for cardiovascular disease treatment and diagnosis. Bowey K; Tanguay JF; Tabrizian M Expert Opin Drug Deliv; 2012 Feb; 9(2):249-65. PubMed ID: 22235930 [TBL] [Abstract][Full Text] [Related]
56. The prospects of hepatic drug delivery and gene therapy. Wu J; Wu GY; Zern MA Expert Opin Investig Drugs; 1998 Nov; 7(11):1795-817. PubMed ID: 15991930 [TBL] [Abstract][Full Text] [Related]
57. Novel materials which possess the ability to target liver cells. Chen Z; Xiao L; Liu W; Liu D; Xiao YY; Chen J; Liu X; Li WD; Li W; Cai BC Expert Opin Drug Deliv; 2012 Jun; 9(6):649-56. PubMed ID: 22480167 [TBL] [Abstract][Full Text] [Related]
58. [Liposomes--prospective vectors of pharmacological agents]. Todorov D; Vasilev P; Ilarionova M; Maneva K Eksp Med Morfol; 1987; 26(4):58-62. PubMed ID: 3328679 [No Abstract] [Full Text] [Related]
59. Modification of liposomes for liver targeting. Wu J; Zern MA J Hepatol; 1996 Jun; 24(6):757-63. PubMed ID: 8835753 [No Abstract] [Full Text] [Related]
60. Multicompartment systems: A putative carrier for combined drug delivery and targeting. Gautam L; Shrivastava P; Yadav B; Jain A; Sharma R; Vyas S; Vyas SP Drug Discov Today; 2022 Apr; 27(4):1184-1195. PubMed ID: 34906689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]